vs
Side-by-side financial comparison of LendingClub Corp (LC) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
LendingClub Corp is the larger business by last-quarter revenue ($252.3M vs $151.7M, roughly 1.7× Nutex Health, Inc.). LendingClub Corp runs the higher net margin — 20.5% vs 7.8%, a 12.6% gap on every dollar of revenue. On growth, LendingClub Corp posted the faster year-over-year revenue change (15.9% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 16.1%).
LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
LC vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $252.3M | $151.7M |
| Net Profit | $51.6M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 20.5% | 7.8% |
| Revenue YoY | 15.9% | -41.1% |
| Net Profit YoY | 341.0% | -80.8% |
| EPS (diluted) | $0.44 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $252.3M | — | ||
| Q4 25 | $266.5M | $151.7M | ||
| Q3 25 | $266.2M | $267.8M | ||
| Q2 25 | $248.4M | $244.0M | ||
| Q1 25 | $217.7M | $211.8M | ||
| Q4 24 | $217.2M | $257.6M | ||
| Q3 24 | $201.9M | $78.8M | ||
| Q2 24 | $187.2M | $76.1M |
| Q1 26 | $51.6M | — | ||
| Q4 25 | — | $11.8M | ||
| Q3 25 | $44.3M | $55.4M | ||
| Q2 25 | $38.2M | $-17.7M | ||
| Q1 25 | $11.7M | $21.2M | ||
| Q4 24 | — | $61.6M | ||
| Q3 24 | $14.5M | $-8.8M | ||
| Q2 24 | $14.9M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | — | — | ||
| Q4 25 | 18.8% | 20.4% | ||
| Q3 25 | 21.5% | 48.7% | ||
| Q2 25 | 21.7% | 13.8% | ||
| Q1 25 | 7.2% | 38.1% | ||
| Q4 24 | 5.1% | 44.4% | ||
| Q3 24 | 8.9% | 12.3% | ||
| Q2 24 | 10.4% | 7.0% |
| Q1 26 | 20.5% | — | ||
| Q4 25 | — | 7.8% | ||
| Q3 25 | 16.6% | 20.7% | ||
| Q2 25 | 15.4% | -7.3% | ||
| Q1 25 | 5.4% | 10.0% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | 7.2% | -11.2% | ||
| Q2 24 | 8.0% | -0.5% |
| Q1 26 | $0.44 | — | ||
| Q4 25 | $0.36 | $2.34 | ||
| Q3 25 | $0.37 | $7.76 | ||
| Q2 25 | $0.33 | $-2.95 | ||
| Q1 25 | $0.10 | $3.33 | ||
| Q4 24 | $0.08 | $11.56 | ||
| Q3 24 | $0.13 | $-1.72 | ||
| Q2 24 | $0.13 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $329.4M |
| Total Assets | $11.9B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $185.6M | ||
| Q3 25 | — | $166.0M | ||
| Q2 25 | — | $96.7M | ||
| Q1 25 | — | $84.7M | ||
| Q4 24 | — | $40.6M | ||
| Q3 24 | — | $46.9M | ||
| Q2 24 | — | $40.8M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | $329.4M | ||
| Q3 25 | $1.5B | $317.2M | ||
| Q2 25 | $1.4B | $235.3M | ||
| Q1 25 | $1.4B | $176.9M | ||
| Q4 24 | $1.3B | $132.4M | ||
| Q3 24 | $1.3B | $60.4M | ||
| Q2 24 | $1.3B | $62.7M |
| Q1 26 | $11.9B | — | ||
| Q4 25 | $11.6B | $918.5M | ||
| Q3 25 | $11.1B | $964.5M | ||
| Q2 25 | $10.8B | $841.0M | ||
| Q1 25 | $10.5B | $761.9M | ||
| Q4 24 | $10.6B | $655.3M | ||
| Q3 24 | $11.0B | $438.5M | ||
| Q2 24 | $9.6B | $422.4M |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.7B | $70.4M | ||
| Q3 25 | $-770.8M | $99.5M | ||
| Q2 25 | $-713.1M | $27.3M | ||
| Q1 25 | $-339.3M | $51.0M | ||
| Q4 24 | $-2.6B | $54.0K | ||
| Q3 24 | $-669.8M | $6.8M | ||
| Q2 24 | $-932.5M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.9B | $69.0M | ||
| Q3 25 | $-791.8M | $99.2M | ||
| Q2 25 | $-803.8M | $26.5M | ||
| Q1 25 | $-352.3M | $50.9M | ||
| Q4 24 | $-2.7B | $-341.0K | ||
| Q3 24 | $-682.3M | $6.2M | ||
| Q2 24 | $-945.3M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | -1076.0% | 45.5% | ||
| Q3 25 | -297.4% | 37.0% | ||
| Q2 25 | -323.5% | 10.9% | ||
| Q1 25 | -161.8% | 24.0% | ||
| Q4 24 | -1237.8% | -0.1% | ||
| Q3 24 | -338.0% | 7.8% | ||
| Q2 24 | -504.9% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 52.7% | 0.9% | ||
| Q3 25 | 7.9% | 0.1% | ||
| Q2 25 | 36.5% | 0.3% | ||
| Q1 25 | 6.0% | 0.0% | ||
| Q4 24 | 25.0% | 0.2% | ||
| Q3 24 | 6.2% | 0.8% | ||
| Q2 24 | 6.9% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.95× | ||
| Q3 25 | -17.41× | 1.80× | ||
| Q2 25 | -18.68× | — | ||
| Q1 25 | -29.07× | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | -46.33× | — | ||
| Q2 24 | -62.57× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LC
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
